Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis

February 17, 2009

Scientists force evolution to greater infectivity, increasing efficiency of gene delivery

Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy.

In its first gene therapy test, it completely cured human cystic fibrosis lung tissue in culture.

This success with the benign adeno-associated virus (AAV), published this week in the online early edition of the journal Proceedings of the National Academy of Sciences, overcomes a major problem of earlier virus-based gene therapy for cystic fibrosis, and sets the stage for tests in advanced animal models of the disease.

"I think it is worthwhile thinking about clinical therapy at the levels of infection we are achieving," said coauthor David Schaffer, professor of chemical engineering at UC Berkeley.

A new pig model of cystic fibrosis developed last year by Schaffer's colleague, pulmonologist Joseph Zabner of the University of Iowa Hospitals and Clinics in Iowa City, will provide a key test of the virus as a carrier of a gene to replace the mutated gene responsible for the disease.

"If we are able to show that efficient gene transfer can result in gene therapy, if we can cure the lung disease of pigs that have been genetically engineered to have cystic fibrosis lung disease, we should have a real chance of curing cystic fibrosis in humans," Zabner said in an e-mail.

Schaffer's lab is collaborating with groups elsewhere to adapt the virus to gene therapy for other diseases, including Alzheimer's disease and amyotrophic lateral sclerosis (Lou Gehrig's disease).

"Both of those are situations where improvements in the properties of the vehicle can have a significant impact on the success of the therapy," Schaffer said.

Cystic fibrosis (CF) is a common hereditary disease that affects the body's mucus membranes, in particular the lungs, resulting in difficulty breathing and typically in death before the age of 40 from lung or organ failure. One in 4,000 children in the United States is born with CF.

Schaffer and his UC Berkeley colleagues collaborated with Zabner's laboratory to test a technique developed by Schaffer to force the evolution of a virus in ways that make it more effective in gene therapy.

Two years ago, Schaffer and colleagues used the technique to create a variant of AAV that more easily avoids the immune system, allowing the virus to remain in the body long enough to deliver a gene to its intended target.

Using the same technique, the team produced a variant of AAV that is several hundred times more effective at entering lung cells than the natural virus.

Schaffer's technique involves making many mutations in AAV, culturing these variants with cells, and then taking those with specific improved properties - in this case, the ability to infect lung cells - and repeating the process.

"We probably conducted about six rounds of evolution in which we infected the lung epithelial cultures in Iowa, they sent it back to us, we recovered the viral sequences, made new viruses and sent them back again," Schaffer said. "It was iterative rounds of infection and selection for improved infection that finally led to this enhancement of function."

The main problem in CF is a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene that results in a defective chloride ion channel in the body's cells. This, in turn, creates a chloride ion imbalance in the cell, which interferes with water transport in and out of the cell. In the lungs, this causes the mucus that lines the lung surface to become thick and sticky. Breathing becomes difficult if the mucus is not loosened, often by vigorous pounding on the chest, and coughed out. Respiratory infections are common, and lung failure often results. The ion channel defect also affects digestion, leading to nutritional deficiency.

According to Schaffer, previous attempts to deliver a normal CFTR gene to lung cells by means of a virus failed either because the immune system mopped up the virus before it had a chance to deliver its cargo, as was the case with adenovirus; or because the virus was inefficient at delivering the gene to cells, the case with adeno-associated virus. Most respiratory viruses tend to have low infection rates, apparently because they would otherwise quickly wipe out their host, Schaffer said.

Schaffer's technique forced the normally benign AAV, which has already infected over 90 percent of people without any harmful side effects, through rounds of directed evolution to increase its infectivity several hundred-fold.

"We devised a way to evolve viruses that are released from the natural constraints of evolution and have the freedom or ability to evolve toward properties that are more useful for medical application," he said. "In human lung tissue, it completely rescued the chloride ion transport properties of the cells after delivering the correct copy of the CFTR gene to replace the mutated copy of the gene that is present in cystic fibrosis patients."

In this case, the infectious AAV strain developed two major changes: Thanks to a mutation on the viral surface, it was able to bind to different receptors or bind to a more plentiful receptor on the cell surface; and it also acquired a mutation that gave the virus an enhanced ability to make it past the cell surface membrane, slip past the lipid bilayer and reach the inside the cell.

"Neither change alone was enough; it had to be the combination of the two that resulted in the improved properties," said Schaffer. "If we decided to use rational design, we wouldn't have known this. So, we left it up to evolution to discover the answer."

University of California - Berkeley

---

---

	Cystic Fibrosis: A Guide for Patient and Family by David Orenstein (Author), Jonathan E. Spahr MD (Author), Daniel J. Weiner MD (Author) This one-of-a-kind guide offers easy-to-understand explanations, advice, and management options for patients or parents of patients with cystic fibrosis. The book explains the disease process, outlines the fundamentals of diagnosing and screening, and addresses the challenges of treatment for those living with CF. As one reviewer said, this book “is the only complete answer book for everyone living with the disease. It is an indispensable resource for families of children with CF, adolescent and adult patients, and physicians, nurses, respiratory therapists, and social workers involved in the care of CF patients.”
	Cystic Fibrosis: Defeated With Natural Self-Oxygenation Methods In this groundbreaking book on cystic fibrosis, Dr. Artour Rakhimov analyzes well over 150 Western medical research studies related to causes of cystic fibrosis (low body oxygen levels), effects of low body oxygen content on transport of ions and the immune system, breathing parameters and oxygen transport in people with cystic fibrosis. He also reviews key conclusions and successful clinical experience of Soviet and Russian medical doctors in treatment of cystic fibrosis. Medical studies clearly proved that tissue hypoxia creates problems in the work of tiny ionic pumps that transport chemicals, such as Na and Cl, and water across the epithelial layers. This effect present even in healthy people, but more expressed in people with cystic fibrosis due to the presence of the...
	Cystic Fibrosis & the Brewer's Yeast: A Microbiology Tale by David G Wooster Ph.D (Author) The story of how microbes and the diseases they cause have come to influence our modern everyday world, sometimes over thousands of years, a guide to ancient history, and the personal memoir of one microbiologist's attempts to gain tenure at his small college in Montana all woven into one book as told by the scientist himself. By the time you finish reading the fourth and final part, you'll know not only the history of brewing, wine making, and baking bread, but also how the 3-atom molecule called "water" is necessary for all biological systems on Earth from the simplest bacteria to trees & human beings, what proteins are and why they are the most important molecules in your body, the connection between cholera & cystic fibrosis, and how all living cells obtain energy from their...
	Taking Cystic Fibrosis to School by Cynthia S. Henry (Author), Tom Dineen (Author), Tom Dineen (Author), Cynthia S. Henry (Author), Tom Dineen (Illustrator) These beautifully illustrated and fun-to-read storybooks simplify and normalize complicated childhood conditions, like cystic fibrosis. When read aloud, other children can identify why a peer may be treated differently and begin to empathize with them. In addition, children whose conditions set them apart as being different begin to feel accepted and safe. Each book includes a Kids' Quiz to reinforce new information and Ten Tips for Teachers to provide additional facts and ideas for teacher use. In Taking Cystic Fibrosis to School, Jessie explains to her classmates that even though she has cystic fibrosis, she can still attend school.
	Beyond Breathing by Margarete Cassalina (Author) Beyond Breathing is a story of a mother's loss of her 13 year old daughter, Jena, to Cystic Fibrosis, a fatal genetic disease. Her journey takes you from unfathomable heartache to love and understanding of life's realities. Through her journey she learns that life lessons come from her children and the beauty of living and the power of love. In the span of one year she learns to go from depression and dependency to inner strength and the realization that love never ends and that there are no coincidences. That she is beyond just breathing.
	The Power of Two: A Twin Triumph over Cystic Fibrosis by Isabel Stenzel Byrnes (Author), Anabel Stenzel (Author) The tragedy of cystic fibrosis has been touchingly recounted before, but this is the first book to portray the symbiotic relationship between twins who share this life-threatening disease through adulthood. Isabel Stenzel Byrnes and Anabel Stenzel tell of their struggle to pursue normal lives while grappling with the realization that they might die young. Their story reflects the physical and emotional challenges of a particularly aggressive form of CF and tells how the twins bicultural heritage Japanese and German influenced the way they coped. The Power of Two is an honest and gripping portrayal of day-to-day health care, the impact of chronic illness on marriage and family, and the importance of a support network to continuing survival. These two remarkable sisters have much to teach...
	Every Precious Breath:Inspirational Stories about Living with Cystic Fibrosis by Tom Valenta (Author) In Every Precious Breath the author tells the story of his two grandsons and discovers that people living with CF and their families are very special people. Their ability to overcome hardships, endure pain and laugh at adversity is inspirational. The book follows the life and death experiences of people with CF and their families. For families there is the burden of caring for a child who every day requires dozens of pills, inhaled medicines and airway clearance. There are the frequent trips to clinics, hospital and hospital in the home. For people with CF there is the knowledge that they have shorter life expectancy than their peers, that they may require lung and other organ transplants and that their ambitions for family and career will be tempered by their condition. For them every...
	Cystic Fibrosis: Everything You Need To Know (Your Personal Health) by Wayne Kepron MD FRCPC (Author) Cystic fibrosis afflicts approximately 30,000 Americans. The average age of survival has been steadily increasing, but not quickly enough: a child born with cystic fibrosis today can only expect to live 35 to 40 years. In this valuable new addition to the Your Personal Health series, Dr. Wayne Kepron offers a comprehensive look at the disease that afflicts so many young people. Topics include: Symptoms of cystic fibrosis Making a diagnosis Complications of the disease Treatments (including lung transplants) Techniques and precautions in lung care Transition into adulthood Prospects for gene therapy End-of-life issues Using diagrams, charts and case studies, Cystic Fibrosis is designed for patients, their families, and caregivers. It is both a quick reference guide and a...
	Cystic Fibrosis (Orml: Oxford Respiratory Medicine Library) by Alex Horsley (Author), Steve Cunningham (Author), Alistair Innes (Author) Cystic fibrosis is the most common life-threatening inherited disease in the UK and Europe. It affects around 1 in 2500 live births in the UK. There have been enormous advances in the treatment of CF over the last 40 years, with life expectancy increasing from just 5 years in 1964 to mid 30s today, and it now affects as many adults as children. The burden of care for CF patients is, however, considerable, and with the increase in life expectancy the impact of CF on respiratory medicine has increased considerably. Part of the Oxford Respiratory Medicine Library series, this pocketbook aims to be a concise companion for all health care professionals who manage, or come across, patients with CF. The book covers all aspects of care, including both paediatric and adult-specific issues. The...
	The Secret Life of Water: A Microbiology Tale Ben Ketchum is a microbiologist and he's just returned from Egypt, where he learned all about the surprising brewer's yeast. Now he's being offered a chance to work on another project he knows little about: cholera. Join him as he learns about cholera, mentors students in his research laboratory, discovers the relationship between water-born diseases & cystic fibrosis, searches for his tenure, finds out about the peculiar chemistry of the water molecule, how Egyptians mummified their dead using salt, this and a lot more. This fictional novella is based on a true story and is the second part of a four-part book called "Cystic Fibrosis & the Brewer's Yeast". __ Book includes many interesting facts about water, its chemistry, and biological...